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Abstract: The current study examined the effects of electroconvulsive therapy (ECT) on 
neuropsychological test performance. Forty-six patients completed brief neuropsychological 
and psychological testing before and after receiving ECT for the treatment of recalcitrant and 
severe depression. Neuropsychological testing consisted of the Levin Selective Reminding Test 
(Levin) and Wechsler Memory Scale-Revised Edition (WMS-R). Self-report measures included 
the Beck Depression Inventory (BDI), the Short-Term Memory Questionnaire (STMQ), and 
several other measures of emotional functioning and patient attitudes toward ECT. The mean 
number of days between pre-ECT and post-ECT testing was 24. T-test revealed a signiﬁ  cant 
decrease in subjective ratings of depression as rated by the BDI, t(45) = 9.82, P  0.0001 (Pre-
BDI = 27.9 ± 20.2; post-BDI = 13.5 ± 9.7). Objective ratings of memory appeared impaired 
following treatment, and patients’ self-report measures of memory conﬁ  rmed this decline. More 
speciﬁ  cally, repeated measures MANOVA [Wilks Lambda F(11,30) = 4.3, p  0.001] indicated 
signiﬁ  cant decreases for measures of immediate recognition memory (p  0.005), long-term 
storage (p  0.05), delayed prose passage recall (p  0.0001), percent retained of prose passages 
(p  0.0001), and percent retained of visual designs (p  0.0001). In addition, the number of 
double mentions on the Levin increased (p  0.02). This study suggests that there may be a 
greater need to discuss the intermittent cognitive risks associated with ECT when obtaining 
informed consent prior to treatment. Further that self-reports of cognitive difﬁ  culties may persist 
even when depression has remitted. However, patients may not acknowledge or be aware of 
changes in their memory functioning, and post-ECT self-reports may not be reliable.
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Introduction
Electroconvulsive therapy (ECT) remains a widely used efﬁ  cacious treatment for a 
variety of complicated psychiatric conditions, particularly affective disorders resis-
tant to psychotherapy, medication, and other forms of treatment (Chamberlin and 
Tsai 1998; Rami-Gonzalez et al 2001). Speciﬁ  cally, ECT has been found to decrease 
symptoms associated with intractable depression (Neylan et al 2001; Taieb et al 2001) 
but sometimes at the temporary cost of decreased speed of information processing 
(Tsourtos et al 2007).
Despite the noted success of this medical procedure in terms of decreasing depres-
sion, several cognitive side effects have been noted. These include an acute confused 
state immediately following the procedure, postictal delirium, interictal disorientation, 
and anterograde and retrograde memory disturbances (Durr and Golden 1995). The 
most notable cognitive side effect has been an iatrogenic form of transient amnesia, 
similar to that caused by anticholinergic drugs (Kopelman 1986; Kopelman and Corn 
1988) and benzodiazepines (Curran 1991, 1986).
The adverse effects of ECT on cognitive functioning, particularly memory, are 
typically more pronounced and have been known for some time (Janis and Astrachan Neuropsychiatric Disease and Treatment 2008:4(3) 614
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1951; Hihn et al 2006; Fujita et al 2006) However, there is 
still controversy regarding the impact these memory difﬁ  cul-
ties may have, as some regard them as limited and tolerable 
(Abraham et al 2006). Several hypotheses have been set 
forth to address the controversy. The changes in cognitive 
decline have been attributed to decreases in hippocampal 
volume (Lekwauwa et al 2006), which may vary depending 
upon electrical waveform and electrode placement (Sackeim 
et al 2007), as well as the type of induction agents (Larsen 
et al 2005). In contrast, animal models have suggested the 
differences in gene expression may inﬂ  uence cognitive 
decline post-ECT (McDaniels et al 2006). Others suggest 
that social stigma surrounding ECT may limit its use, effec-
tiveness, and compromise scientiﬁ  c exploration that may aid 
in determining the mechanisms associated with cognitive 
decline (Melding 2006).
Squire (1977) investigated the effects of ECT on cog-
nitive functioning and found that bilateral ECT produced 
greater anterograde memory loss than right unilateral ECT 
on both recall and recognition memory tests. In addition, 
bilateral ECT was associated with more extensive retrograde 
amnesia than unilateral ECT and that the capability to form 
new memories substantially recovered 6–9 months after 
unilateral ECT. Unfortunately, continued memory complaints 
were common among individuals who received bilateral 
ECT. Several other studies have revealed similar long-term 
consequences of ECT (Weeks et al 1980; Frith et al 1983; 
Squire et al 1984; Sackeim 1992; Sackeim et al 2007).
Despite a relatively complete recovery of memory 
functioning several months following ECT in a majority of 
patients, many individuals complain of continued memory 
deﬁ  cits 3 years or more after treatment. However, these com-
plaints may be due to a lack of improvement in depressive 
symptoms. Several researchers have found that ECT patients 
who continue to experience depressive symptoms complain 
of more memory loss as compared with their counterparts 
whose depressive symptoms go into remission, but do not 
demonstrate memory deﬁ  cits on neuropsychological evalua-
tion (Freeman et al 1980; Squire and Slater 1983; Frith et al 
1983). Furthermore, depressive symptoms or medication 
were not associated with deﬁ  cits on tests of logical memory, 
face-name recall and verbal learning (Freeman et al 1980). 
This suggests that depressive symptoms may have an inﬂ  u-
ence on self-report cognitive deﬁ  cits but are not associated 
with neurocognitive testing performance.
More recent empirical evidence suggests that patients 
report improvements in cognitive functioning post-ECT. 
Coleman and colleagues (1996) found that, at baseline, 
patients reported marked deﬁ  cits on a self-report measure 
of memory functioning. However, these patients reported 
improved memory functioning shortly following ECT, 
despite objective test results indicating impaired anterograde 
and retrograde memory deﬁ  cits at that time. Improvements 
in self-reported memory functioning were less pronounced 
among patients who received high dosage ECT stimulation 
and/or bilateral electrode placement. In contrast to previous 
literature, this evidence suggests that low dosage ECT, and 
to some extent, high dosage ECT may be associated with 
increased self-report memory functioning. Coleman and 
colleagues (1996) suggested that this difference might reﬂ  ect 
the changes in ECT practices. Despite the positive implica-
tions of the Coleman and colleagues’ (1996) ﬁ  ndings, more 
evidence is needed to support the positive effects of ECT on 
self-report memory functioning.
The purpose of the present study was to investigate the 
relationship between self-reported memory functioning, 
objective measures of memory functioning, and self-reported 
mood. The study further will provide evidence for memory 
functioning of patients prior to and after receiving ECT.
Method
Design
Using archival methods, we reviewed the medical records of 46 
sequential patients seen at a southeastern USA medical facility 
for neuropsychological evaluation prior to and after ECT.
Participants
All participants were referred with a primary diagnosis 
of major depression, recurrent, severe without psychotic 
features (N = 46). Of the 46 participants (30 females), 40 
completed the neuropsychological evaluation as inpatients at 
the hospital. The vast majority of participants were Caucasian 
(N = 44), the mean age was 56.2 years (SD = 17.32; range 
19–96), and the mean years of education was 13.6 (SD = 3.2). 
The mean number of days between the pre- and post-ECT 
neuropsychological evaluations was 24.5 days (SD = 11.4).
Clinical assessment instruments 
and procedures
All participants completed neuropsychological tests consisting 
of the Short-Term Memory Questionnaire (STMQ; Koss et al 
1993), Levin Selective Reminding Test (Levin: Hannay & 
Levin 1985), and the Logical Memory and Visual Reproduc-
tion subtests from the Wechsler Memory Scale (WMS-R) on 
the day prior to ECT. Psychological tests included the Beck Neuropsychiatric Disease and Treatment 2008:4(3) 615
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Depression Inventory (BDI) and several other self-report 
measures of emotional functioning and patient attitudes 
toward ECT.
Results
For the current analyses, we utilized a set of simple paramet-
ric procedures to detect difference in means as a function of 
their standard deviations, and the total sample size. Simple 
2 group comparisons were made using T-tests. Multivariate 
analysis of variance was used to evaluate the simultaneous 
effects of time on multiple dependent variables. Due to lim-
ited sample size, we did not utilize models of covariance for 
age and other demographic factors in the current analyses.
T-test revealed a signiﬁ  cant decrease in subjective ratings 
of depression as rated by the BDI, t(45) = 9.82, p  0.0001. 
Table 1 presents the means on the BDI. A repeated measures 
MANOVA indicated a signiﬁ  cant effect of time on neuro-
psychological measures of verbal and visual memory, Wilks 
Lambda F(11,30) = 4.3, p  0.001. On a verbal list-learning 
test (Levin), there was a signiﬁ  cant decrease in long-term 
storage and immediate recognition memory following 
ECT. A signiﬁ  cant increase in the number of repetitions on 
the Levin was noted. Similarly, delayed recall and percent 
retained for paragraph length were signiﬁ  cantly decreased 
after ECT (p-values; or effect size). With respect to visual 
memory, the percent retained for geometric designs was also 
signiﬁ  cantly decreased following ECT. Tables 2 and 3 pres-
ent the results for the neuropsychological measures.
Patients’ self-report of memory functioning after ECT 
was somewhat inconsistent. On the Short-term Memory 
Questionnaire (SMQ), patients did not report a signiﬁ  cant 
change in their memory functioning after ECT (p  0.35). 
The SMQ means presented in Table 4 are consistent with 
previous results (Koss et al 1993) which indicate memory 
deﬁ  cits, although not to a level of mild dementia. Differ-
ences between pre- and post-ECT were observed on another 
self-report measure that asked patients to rate memory 
impairments on a temporal gradient that ranged from 10 
minutes ago to 21–30 years ago. On this measure, patients 
indicated poorer short-term memory (those events which 
occurred 10 minutes ago) and long-term memory (those 
events which occurred one month ago) functioning. These 
ﬁ  ndings were conﬁ  rmed with signiﬁ  cant decreases on global 
self-report measures of memory dysfunction in the past 
week (p  0.03).
Nonparametric analysis (Wilcoxon Signed Ranks Test) 
revealed that patients’ attitudes towards ECT changed after 
completing their treatments. Speciﬁ  cally, patients rated ECT 
to be more effective than drugs (p  0.005) in treating their 
depression.
Discussion
The results of this study support the ﬁ  ndings of previous 
research indicating that ECT results in decreased memory 
functioning. The results of the current study indicate rela-
tively immediate and signiﬁ  cant decreases in multiple areas 
of memory following ECT compared with pre-ECT levels of 
functioning including verbal memory for word lists and prose 
passages and visual memory of geometric designs.
Table 1 Beck Depression Inventory score pre- and post-ECT
Variable Mean  (SD)  Range
Pre-ECT raw score  27.9 (20.2)  20–62
Post-ECT raw score  13.5 (9.7)  0–39
Abbreviation: ECT, electroconvulsive therapy.
Table 2 Levin Selective Reminding Test scores pre- and post-ECT
Variable  Pre-ECT   Post-ECT   p value
  Mean (SD)  Mean (SD)
Long-term storage  27.4 (18.6)  21.4 (14.4)  NS
Consistency of long-term  18.4 (17.6)  13.1 (11.5)  NS
storage
Immediate recognition  10.1 (5.6)  9.7 (2.3)  0.01
memory
Intrusions 1.6  (2.5)  1.2  (1.4)  NS
Double mentions  3.2 (3.3)  1.9 (2.8)  0.001
Abbreviation: ECT, electroconvulsive therapy.
Table 3 Wechsler Memory Scale scores pre- and post-ECT
Variable Pre-ECT  Post-ECT  p  Value
  Mean (SD)  Mean (SD)
Immediate verbal memory  14.9 (6.5)  14.6 (6.0)  NS
Delayed verbal memory  10.4 (6.6)  6.9 (6.7)  0.001
% Retained for verbal   64.1 (27.3)  40.8 (28.2)  0.001
memory
Immediate visual memory  6.4 (4.0)  6.9 (4.3)  NS
Delayed visual memory  5.1 (3.8)  4.2 (3.9)  NS
% Retained for visual memory  72.4 (31.6)  53.2 (35.4)  0.001
Abbreviation: ECT, electroconvulsive therapy.
Table 4 Means for the Short-Memory Questionnaire
 Mean  (SD)
Pre-ECT 39.7  (8.3)  ns
Post-ECT 41.6  (7.3)  ns
Abbreviation: ECT, electroconvulsive therapy.Neuropsychiatric Disease and Treatment 2008:4(3) 616
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Contrary to the established literature, patients indicated 
memory deﬁ  cits both before and after receiving ECT, but 
did not report a signiﬁ  cant change in their subjective rat-
ings of memory functioning. Indeed, there was a slight 
trend towards improved memory functioning, despite the 
objective neuropsychological data indicating signiﬁ  cantly 
lower recognition and delayed recall. Thus, self-appraisal 
of memory functioning seems to be impacted and should 
be further explored to better understand these ﬁ  ndings. As 
expected, patients self-reported levels of depression were 
signiﬁ  cantly lower following ECT. Thus, the results indicate 
that ECT was successful in alleviating depressive symptom-
atology while cognitive deﬁ  cits persisted with poor insight 
of cognitive decline post ECT.
The current results stress the need for providing a 
signiﬁ  cant level of informed consent to patients prior to 
receiving ECT and the need for additional efforts to assure 
that written information is comprehended (Edwards and 
Rogers 2007). This need is further argued when considering 
ECT for older adults. For instance, the implications of such 
memory changes associated with an older adults’ real-world 
functioning should be discussed, particularly if the patient is 
living independently. Perhaps, development of compensatory 
strategies should be implemented to assist the patient as they 
recover following such treatment (ie, using post-it-notes, 
family assistance, reminders, pill box, calendars, etc). This 
may help to reduce or minimize potential risks for other 
problems (ie, forgetting to take medications for medical 
problems, safety, etc).
Durr and Golden (1995) purport that this is particularly 
important to consider when older adults with preexisting 
cognitive or neurological dysfunction are at greater risk of 
cognitive disturbances resulting from ECT. Consideration of 
use of medications and behavioral techniques that reduce the 
impact of ECT on memory should be considered (Prakash 
et al 2006; MacQueen et al 2007). When ECT is provided to 
adolescents, the potential impact of such cognitive changes 
should be discussed with the patients and their parents or 
guardians in terms of implications for not only the patient’s 
emotional functioning but cognitive functioning as well, 
particularly upon his or her academic performance. In sum-
mary, we argue that an individual cost-beneﬁ  t analysis should 
be made in light of the implications of the potential beneﬁ  ts 
versus costs of ECT upon improving emotional functioning 
and the impact that potential memory changes may have on 
real-world functioning and quality of life.
The archival nature of the current methodology serves as 
a potential limitation to this study. For example, our ability 
to collect data on medications and evaluate the inﬂ  uence 
of these medications on mood and memory at the time of 
intervention was extremely limited due to the retrospective 
nature of the data collection. Further, data about the techni-
cal parameters of the ECT procedure (mean seizure length, 
electrode placement, etc) were not available to us at the time 
of the review. However, archival methodology can facilitate 
documentation of observed phenomena in a fashion that 
promotes the development of future prospective studies. We 
view the value of the current study in such a context.
We also recognize that our limited sample size could be 
of concern to some readers. More speciﬁ  cally, we utilized 
conservative techniques to model relationships between 
variables and to control for factors that could account for 
additional variance in our analyses. We view this as a reason-
able trade-off to document the current ﬁ  nding and inspire new 
science related to the cognitive affects of ECT. Although we 
noted at least one statistically signiﬁ  cant ﬁ  nding in our results 
that was not equally clinically meaningful, we believe that 
highlighting differences between subjective appraisals and 
objective measures of memory have clinical signiﬁ  cance. 
We also note published studies in the ECT literature that are 
equally plagued with this common issue but contributing to 
our knowledge of the impact of ECT on cognitive factors 
(Datka et al 2007).
Future research should focus on delineating speciﬁ  c 
cognitive changes associated with the use of ECT in different 
age groups, the time course to recovery and identifying rec-
ommendations and appropriate strategies to compensate for 
temporary cognitive changes upon discharge and to promote 
insight into such decline (Blaj et al 2007). These results fol-
low some recommendations (Neylan et al 2001) which argue 
that the identiﬁ  cation of risk factors for ECT-related cogni-
tive side effects need to be better characterized in an effort 
to assist clinicians with informing patients of such risks and 
to potentially implement prophylactic interventions. These 
results also urge for continued research in the area of ECT and 
neurocognitive changes to identify patient-speciﬁ  c factors that 
may contribute to ECT-induced cognitive impairment.
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